According to the latest reports, CME Group has announced it will launch options on Solana and XRP futures starting October 13, 2025, pending regulatory approval. This is a big step beyond Bitcoin and Ethereum derivatives as CME is responding to a surge in trading volume, open interest and institutional demand for SOL and XRP futures.
The Solana and XRP Options will be available in standard and micro contract sizes with expiries daily, monthly and quarterly.
New Options Structure and Features
CME’s new options will allow trading on SOL, Micro SOL, XRP and Micro XRP futures. They will have different expiration frequencies such as every business day, every month and quarterly. This will give institutional players and active individual traders more flexibility to hedge or speculate with defined risk.
Giovanni Vicioso, CME’s Global Head of Crypto Products, said these contracts are built on the growth and liquidity of SOL and XRP futures. Joshua Lim of FalconX noted the rise of digital asset treasuries has created the need for these hedging tools.
Also read: Why Bitcoin is Dropping: The CME Trade Strategy Breakdown

SOL and XRP Futures Demand Surges
Since March 2025, over 540,000 SOL futures have traded, representing $22.3 billion in notional value. In August, SOL futures saw record daily volume of 9,000 contracts and daily open interest of 12,500 contracts, or $895 million in notional value.
XRP futures, which launched in May 2025, have traded over 370,000 contracts, with cumulative notional of $16.2 billion. August for XRP futures also saw new highs with daily volume of 6,600 contracts and open interest of $942 million. All these suggest a booming market adoption ahead of the options launch.
Institutional and Market Implications
The Solana and XRP Options bring tools that were previously unavailable to SOL and XRP participants in regulated U.S. markets. Institutions can now use options to hedge downside or volatility. Micro-contracts mean smaller traders can access these tools more affordably.
More liquidity in the futures markets; means tighter bid-ask spreads and lower slippage. With demand for SOL and XRP futures already strong; the options could increase trading activity; tighten implied volatility and potentially attract more institutional capital to these assets.
Regulatory Context and Approval Status
The Solana and XRP Options launch date, slated for October 13, 2025 is still pending regulatory review. CME Group’s announcement says standard regulatory checks including self-certification under U.S. Commodity Futures Trading Commission (CFTC) rules and internal risk and clearing processes under CME Clearing must be completed.
Contract sizes, expirations and micro vs standard formats are designed to meet both regulatory and market participant needs. The CME CF Reference Rate will be used for these options to ensure price transparency.
Risks and What to Watch
Though demand looks strong but there are risks. Regulatory review may delay or modify the launch, especially for the less liquid expiries. Liquidity providers may focus on standard contracts first, leaving micro contracts less liquid or more volatile. Open interest and notional size may concentrate in certain maturities and create mismatches in pricing.

There may be divergence between CME listed derivatives and off exchange or unregulated markets for SOL and XRP. Traders will need to watch trading volumes, open interest, expiries’ liquidity and how the market absorbs options related to volatile asset behavior.
Also read: Ripple’s Big Break: CME Futures Live May 19—Spot ETF Next in Line?
Conclusion
Based on the latest research, the Solana and XRP options launch at CME is a big one for altcoin derivatives. These are backed by strong evidence of futures demand, institutional interest and growing liquidity in SOL and XRP futures markets.
With options in micro and standard form and expiries from daily to quarterly, market participants will have more precision in risk management.
For investors and traders alike, the options launch could bring more price discovery, liquidity and hedging capacity in SOL and XRP markets.
For in-depth analysis and the latest trends in the crypto space, our platform offers expert content regularly.
Summary
CME will start options trading on Solana and XRP futures October 13, 2025 pending approval. Offerings include micro and standard contracts with daily, monthly and quarterly expiries. Futures volume and open interest in both SOL and XRP have grown this year so the demand is there.
Glossary
Option contract: a derivatives instrument that gives the holder the right but not the obligation to buy or sell the asset at a predetermined price before or at expiry.
Micro contract: a smaller version of a standard futures or options contract, for smaller traders or institutions to take positions with less capital.
Open interest: the total number of outstanding derivative contracts (futures or options) that have not been settled.
Notional value: the total value of derivative contracts; calculated as contract size times price.
Futures contract: an agreement to buy or sell an asset at a predetermined price at a future date; differs from options in that it’s an obligation.
Frequently Asked Questions about Solana and XRP Options
What does “pending regulatory approval” mean for these new options?
CME still needs to self-certify with the U.S. CFTC, put risk-management and clearing in place and meet other regulatory hurdles before trading can begin.
Will retail traders be able to trade these options or is it for institutions only?
Retail traders with access to intermediaries that support CME derivatives will likely be able to trade micros. Standards may require higher margin and institutional grade access.
How will options change SOL and XRP price behaviour?
Options will introduce hedging possibilities that could lower implied volatility, allow more precise risk management and improve liquidity.
Could there be any delay or cancellation of the launch?
Yes. Although announced, the launch is subject to regulatory reviews. If approvals aren’t granted or requirements aren’t met, CME may delay or adjust the product specs.